Trust in government, intention to vaccinate and Covid-19 vaccine hesitancy

A comparative survey of five large cities in the United States, United Kingdom, and Australia

Datos Bibliográficos

ID23324699
AutoresMallory Trent (0000-0001-5264-2660, UNSW Sydney, autor de correspondencia), Holly Seale (0000-0002-1877-5395, UNSW Sydney), Abrar Ahmad Chughtai (0000-0003-4203-7891, The University of Sydney), Daniel A Salmon (0000-0002-1035-4422, Johns Hopkins University), Daniel Salmon, C Raina Macintyre (0000-0002-3060-0555, UNSW Sydney)
Año2022
Volumen40
Número17
Páginas2498-2505
Fecha de publicación2022-04-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaVaccine (JOURNAL)
Identificadores de la revistaISSN: 0264-410X • E-ISSN: 1873-2518
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.vaccine.2021.06.048
PMID34218963
OpenAlexW3176235170
IdiomaEN
Citas recibidas87
Referencias citadas26

BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. PARTICIPANTS, SETTING: Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. MAIN OUTCOMES AND MEASURES: Willingness to receive a COVID-19 vaccine; reason for vaccine intention. STATISTICAL METHODS: To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios. RESULTS: The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07-1.44 and PR = 1.38; 95% CI = 1.74-1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72-0.85 and PR = 0.85; 95% CI = 0.76-0.96). LIMITATIONS: Consumer panels can be subject to bias and may not be representative of the general population. CONCLUSIONS: Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine.

Confidence interval · Coronavirus disease 2019 (COVID-19) · Disease · Environmental health · Family medicine · Government (linguistics) · Phoenix · Poisson regression · Population · Vaccination · COVID-19 Impact on Reproduction · Demography · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Virology